Savara to present at the jefferies london healthcare conference

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the jefferies london healthcare conference on november 15, 2023 at 12:00pm gmt/7:00am est. a live webcast of the fireside chat will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. about savara savara is.
SVRA Ratings Summary
SVRA Quant Ranking